Cargando…
Ifosfamide-induced nephrogenic diabetes insipidus responsive to supraphysiologic doses of intravenous desmopressin
Nephrogenic diabetes insipidus (DI) refers to the reduction in the ability of the kidney to concentrate urine, which can be caused by partial or complete resistance at the site of action of anti-diuretic hormone (ADH) in the collecting tubules. Ifosfamide-induced nephrogenic DI typically occurs conc...
Autores principales: | Sohail, Mohammad A., Hassanein, Mohamed, Rincon-Choles, Hernan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259464/ https://www.ncbi.nlm.nih.gov/pubmed/34235046 http://dx.doi.org/10.5414/CNCS110589 |
Ejemplares similares
-
Oral disintegrating desmopressin tablet is effective for partial congenital
nephrogenic diabetes insipidus with AVPR2 mutation: a case
report
por: Ikegawa, Kento, et al.
Publicado: (2022) -
ODP336 Nephrogenic Diabetes Insipidus and Fanconi Syndrome Induced by Ifosfamide in a Patient with Femur Osteosarcoma. A Case Report
por: Ramos-Torres, Guillermo, et al.
Publicado: (2022) -
Ifosfamide-induced Fanconi syndrome with diabetes insipidus
por: Leem, Ah Young, et al.
Publicado: (2014) -
Acquired nephrogenic diabetes insipidus in a dog with leptospirosis
por: Etish, Jamie L, et al.
Publicado: (2014) -
Partial nephrogenic diabetes insipidus associated with Castleman’s disease
por: Kim, Minah, et al.
Publicado: (2019)